BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2004406)

  • 1. [The past and the present of cardiac glycosides. III. Pharmacokinetics].
    Synek P
    Cas Lek Cesk; 1991 Feb; 130(5):148-51. PubMed ID: 2004406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P
    Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-related alterations in cardiac glycoside disposition.
    Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
    Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of cardiac glycosides and clinical consequences].
    Rietbrock N; Kuhlmann J; Vöhringer HF
    Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal elimination kinetics of various several cardiac glycosides].
    Kramer P; Scheler F
    Dtsch Med Wochenschr; 1972 Oct; 97(40):1485-90. PubMed ID: 5071762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern cardiac glycoside therapy].
    Bonelli J
    Wien Med Wochenschr; 1978; 128(22):689-96. PubMed ID: 735108
    [No Abstract]   [Full Text] [Related]  

  • 9. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency].
    Rietbrock N; Woodcock BG; Hrazdil U
    Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the ocular distribution of cardiac glycosides in guinea pigs following acute administration.
    Duncker G; Herzig S
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(1):55-9. PubMed ID: 2920909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FACTORS INFLUENCING THE ACTION OF CARDIAC GLYCOSIDES ON ISOLATED EMBRYONIC CHICK HEART. I. EFFECTS OF SERUM AND CORTISOL ON THE ACTION OF CARDIAC GLYCOSIDES].
    UCHIDA S
    Yakugaku Zasshi; 1964 Jul; 84():596-601. PubMed ID: 14221199
    [No Abstract]   [Full Text] [Related]  

  • 14. Elimination of cardiac glycosides through hemofiltration.
    Kramer P; Matthias C; Matthaei D; Scheler F
    J Dial; 1977; 1(7):689-95. PubMed ID: 608877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of induced cholestasis on pharmacokinetics of digoxin and digitoxin in dogs.
    Miyazawa Y; Sato T; Kobayashi K; Akahori F; Suzuki T; Miyashita H
    Am J Vet Res; 1990 Apr; 51(4):605-10. PubMed ID: 2327624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
    Kuhlmann J
    Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effective concentration and dosage for cardiac glycosides].
    Weiss M; Förster W
    Z Gesamte Inn Med; 1980 Jan; 35(1):1-7. PubMed ID: 6996345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
    Reissell P; Manninen V
    Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and problems or long-term therapy using cardiac glycosides].
    Gillmann H
    Z Gesamte Inn Med; 1973 Feb; 28(3):41-5 passim. PubMed ID: 4633782
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.